Bin Huang
Direktor/Vorstandsmitglied bei 3SBIO INC.
Vermögen: 26 Mio $ am 30.04.2024
Aktive Positionen von Bin Huang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| 3SBIO INC. | Direktor/Vorstandsmitglied | 01.01.2006 | - |
| Corporate Officer/Principal | 01.01.1993 | 20.06.2019 | |
Collected Mind Ltd.
 Collected Mind Ltd. Financial ConglomeratesFinance Part of 3SBio, Inc., Collected Mind Ltd. functions as an investment holding There is no available country named vg company. | Direktor/Vorstandsmitglied | 01.08.2006 | - |
| Taizhou Huan Sheng Investment Management Co., Ltd. | Direktor/Vorstandsmitglied | 01.11.2010 | - |
| Vorstandsvorsitzender | 01.11.2010 | - | |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
 Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Direktor/Vorstandsmitglied | 01.01.1993 | - |
| Corporate Officer/Principal | - | - | |
| Personalreferent | 01.01.1993 | - |
Karriereverlauf von Bin Huang
Ehemalige bekannte Positionen von Bin Huang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Chemokine Therapeutics Corp.
 Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | - | - |
Statistik
International
| China | 3 |
| Kanada | 2 |
| Cayman Islands | 2 |
Operativ
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 4 |
| Finance | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| 3SBIO INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Chemokine Therapeutics Corp.
Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | Health Technology |
Collected Mind Ltd.
Collected Mind Ltd. Financial ConglomeratesFinance Part of 3SBio, Inc., Collected Mind Ltd. functions as an investment holding There is no available country named vg company. | Finance |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Health Technology |
